mepolizumab

mepolizumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Immunomodulator (monoclonal antibody).

mepolizumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

mepolizumab Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shanghai Minbiotech Co., Ltd.	+8617315815539	sales@minbiotech.com	CHINA	129	58
Baoji Guokang Healthchem co.,ltd	+8615604608665 15604608665	dominicguo@gk-bio.com	CHINA	9427	58
Hefei Hirisun Pharmatech Co., Ltd	+8615056975894	shawn@hirisunpharm.com	CHINA	9923	58
Aladdin Scientific	+1-833-552-7181	sales@aladdinsci.com	United States	57511	58
Wuhan Fortuna Chemical Co., Ltd	027-027-59207852 13308628970	buy@fortunachem.com	China	2893	58
Dalian Meilun Biotech Co., Ltd.	0411-62910999 13889544652	sales@meilune.com	China	4647	58
Beijing HuaMeiHuLiBiological Chemical	010-56205725	waley188@sohu.com	China	12338	58
Taizhou KEDE Chemical Co., Ltd	0576-84613060 13093829633	sales@kedechemical.com	China	298	60
Shanghai Lollane Biological Technology Co.,Ltd.	021-52996696，15000506266 15000506266		China	4121	55
Shanghai EFE Biological Technology Co., Ltd.	021-65675885 18964387627	info@efebio.com	China	9709	58

---

• mepolizumab
• Bosatria
• Immunoglobulin G1, anti-(human interleukin 5) (human-mouse monoclonal sb-240563 gamma1-chain), disulfide with human-mouse monoclonal sb-240563 kappa-chain, dimer
• Sb 240563
• Research Grade Mepolizumab(DHC13602)
• eosinophil proliferation,neutralizes interleukin-5,Interleukin Related,IL-5,Mepolizumab,eosinophilic granulomatosis,humanized monoclonal antibody,polyangiitis,Inhibitor,SB240563,EGPA,activation,SB-240563,eosinophilic asthma,survival,inhibit
• Mepolizumab (anti-IL-5)
• 196078-29-2